Technology in Parkinson's disease: Challenges and opportunities
ABSTRACT The miniaturization, sophistication, proliferation, and accessibility of technologies are enabling the capture of more and previously inaccessible phenomena in Parkinson's disease (PD). However, more information has not translated into a greater understanding of disease complexity to s...
Saved in:
Published in | Movement disorders Vol. 31; no. 9; pp. 1272 - 1282 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Blackwell Publishing Ltd
01.09.2016
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | ABSTRACT
The miniaturization, sophistication, proliferation, and accessibility of technologies are enabling the capture of more and previously inaccessible phenomena in Parkinson's disease (PD). However, more information has not translated into a greater understanding of disease complexity to satisfy diagnostic and therapeutic needs. Challenges include noncompatible technology platforms, the need for wide‐scale and long‐term deployment of sensor technology (among vulnerable elderly patients in particular), and the gap between the “big data” acquired with sensitive measurement technologies and their limited clinical application. Major opportunities could be realized if new technologies are developed as part of open‐source and/or open‐hardware platforms that enable multichannel data capture sensitive to the broad range of motor and nonmotor problems that characterize PD and are adaptable into self‐adjusting, individualized treatment delivery systems. The International Parkinson and Movement Disorders Society Task Force on Technology is entrusted to convene engineers, clinicians, researchers, and patients to promote the development of integrated measurement and closed‐loop therapeutic systems with high patient adherence that also serve to (1) encourage the adoption of clinico‐pathophysiologic phenotyping and early detection of critical disease milestones, (2) enhance the tailoring of symptomatic therapy, (3) improve subgroup targeting of patients for future testing of disease‐modifying treatments, and (4) identify objective biomarkers to improve the longitudinal tracking of impairments in clinical care and research. This article summarizes the work carried out by the task force toward identifying challenges and opportunities in the development of technologies with potential for improving the clinical management and the quality of life of individuals with PD. © 2016 International Parkinson and Movement Disorder Society |
---|---|
AbstractList | The miniaturization, sophistication, proliferation, and accessibility of technologies are enabling the capture of more and previously inaccessible phenomena in Parkinson's disease (PD). However, more information has not translated into a greater understanding of disease complexity to satisfy diagnostic and therapeutic needs. Challenges include noncompatible technology platforms, the need for wide-scale and long-term deployment of sensor technology (among vulnerable elderly patients in particular), and the gap between the "big data" acquired with sensitive measurement technologies and their limited clinical application. Major opportunities could be realized if new technologies are developed as part of open-source and/or open-hardware platforms that enable multichannel data capture sensitive to the broad range of motor and nonmotor problems that characterize PD and are adaptable into self-adjusting, individualized treatment delivery systems. The International Parkinson and Movement Disorders Society Task Force on Technology is entrusted to convene engineers, clinicians, researchers, and patients to promote the development of integrated measurement and closed-loop therapeutic systems with high patient adherence that also serve to (1) encourage the adoption of clinico-pathophysiologic phenotyping and early detection of critical disease milestones, (2) enhance the tailoring of symptomatic therapy, (3) improve subgroup targeting of patients for future testing of disease-modifying treatments, and (4) identify objective biomarkers to improve the longitudinal tracking of impairments in clinical care and research. This article summarizes the work carried out by the task force toward identifying challenges and opportunities in the development of technologies with potential for improving the clinical management and the quality of life of individuals with PD. © 2016 International Parkinson and Movement Disorder Society. The miniaturization, sophistication, proliferation, and accessibility of technologies are enabling the capture of more and previously inaccessible phenomena in Parkinson's disease (PD). However, more information has not translated into a greater understanding of disease complexity to satisfy diagnostic and therapeutic needs. Challenges include noncompatible technology platforms, the need for wide-scale and long-term deployment of sensor technology (among vulnerable elderly patients in particular), and the gap between the "big data" acquired with sensitive measurement technologies and their limited clinical application. Major opportunities could be realized if new technologies are developed as part of open-source and/or open-hardware platforms that enable multichannel data capture sensitive to the broad range of motor and nonmotor problems that characterize PD and are adaptable into self-adjusting, individualized treatment delivery systems. The International Parkinson and Movement Disorders Society Task Force on Technology is entrusted to convene engineers, clinicians, researchers, and patients to promote the development of integrated measurement and closed-loop therapeutic systems with high patient adherence that also serve to (1) encourage the adoption of clinico-pathophysiologic phenotyping and early detection of critical disease milestones, (2) enhance the tailoring of symptomatic therapy, (3) improve subgroup targeting of patients for future testing of disease-modifying treatments, and (4) identify objective biomarkers to improve the longitudinal tracking of impairments in clinical care and research. This article summarizes the work carried out by the task force toward identifying challenges and opportunities in the development of technologies with potential for improving the clinical management and the quality of life of individuals with PD. © 2016 International Parkinson and Movement Disorder Society The miniaturization, sophistication, proliferation, and accessibility of technologies are enabling the capture of more and previously inaccessible phenomena in Parkinson's disease (PD). However, more information has not translated into a greater understanding of disease complexity to satisfy diagnostic and therapeutic needs. Challenges include noncompatible technology platforms, the need for wide-scale and long-term deployment of sensor technology (among vulnerable elderly patients in particular), and the gap between the "big data" acquired with sensitive measurement technologies and their limited clinical application. Major opportunities could be realized if new technologies are developed as part of open-source and/or open-hardware platforms that enable multichannel data capture sensitive to the broad range of motor and nonmotor problems that characterize PD and are adaptable into self-adjusting, individualized treatment delivery systems. The International Parkinson and Movement Disorders Society Task Force on Technology is entrusted to convene engineers, clinicians, researchers, and patients to promote the development of integrated measurement and closed-loop therapeutic systems with high patient adherence that also serve to (1) encourage the adoption of clinico-pathophysiologic phenotyping and early detection of critical disease milestones, (2) enhance the tailoring of symptomatic therapy, (3) improve subgroup targeting of patients for future testing of disease-modifying treatments, and (4) identify objective biomarkers to improve the longitudinal tracking of impairments in clinical care and research. This article summarizes the work carried out by the task force toward identifying challenges and opportunities in the development of technologies with potential for improving the clinical management and the quality of life of individuals with PD. copyright 2016 International Parkinson and Movement Disorder Society ABSTRACT The miniaturization, sophistication, proliferation, and accessibility of technologies are enabling the capture of more and previously inaccessible phenomena in Parkinson's disease (PD). However, more information has not translated into a greater understanding of disease complexity to satisfy diagnostic and therapeutic needs. Challenges include noncompatible technology platforms, the need for wide‐scale and long‐term deployment of sensor technology (among vulnerable elderly patients in particular), and the gap between the “big data” acquired with sensitive measurement technologies and their limited clinical application. Major opportunities could be realized if new technologies are developed as part of open‐source and/or open‐hardware platforms that enable multichannel data capture sensitive to the broad range of motor and nonmotor problems that characterize PD and are adaptable into self‐adjusting, individualized treatment delivery systems. The International Parkinson and Movement Disorders Society Task Force on Technology is entrusted to convene engineers, clinicians, researchers, and patients to promote the development of integrated measurement and closed‐loop therapeutic systems with high patient adherence that also serve to (1) encourage the adoption of clinico‐pathophysiologic phenotyping and early detection of critical disease milestones, (2) enhance the tailoring of symptomatic therapy, (3) improve subgroup targeting of patients for future testing of disease‐modifying treatments, and (4) identify objective biomarkers to improve the longitudinal tracking of impairments in clinical care and research. This article summarizes the work carried out by the task force toward identifying challenges and opportunities in the development of technologies with potential for improving the clinical management and the quality of life of individuals with PD. © 2016 International Parkinson and Movement Disorder Society |
Author | Mitsi, Georgia Kubota, Ken Nahab, Fatta B. Godinho, Catarina Lang, Anthony E. Horne, Malcolm Simuni, Tanya Bloem, Bastiaan R. Espay, Alberto J. Bonato, Paolo Maetzler, Walter Nieuwboer, Alice Krinke, Lothar Litvan, Irene Burack, Michelle A. Little, Max A. Papapetropoulos, Spyros Hausdorff, Jeffery M. Dean, John M. Reilmann, Ralf Dorsey, E. Ray Eskofier, Bjoern M. Daneault, Jean-Francois Merola, Aristide Giuffrida, Joe Kamondi, Anita Horak, Fay Klucken, Jochen |
Author_xml | – sequence: 1 givenname: Alberto J. surname: Espay fullname: Espay, Alberto J. email: alberto.espay@uc.edu, alberto.espay@uc.edu organization: James J. and Joan A. Gardner Family Center for Parkinson's disease and Movement Disorders, University of Cincinnati, Ohio, Cincinnati, USA – sequence: 2 givenname: Paolo surname: Bonato fullname: Bonato, Paolo organization: Department of Physical Medicine and Rehabilitation, Harvard Medical School, Massachusetts, Boston, USA – sequence: 3 givenname: Fatta B. surname: Nahab fullname: Nahab, Fatta B. organization: Department of Neurosciences, University of California San Diego, CA, La Jolla, USA – sequence: 4 givenname: Walter surname: Maetzler fullname: Maetzler, Walter organization: Department of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH), University of Tuebingen, Tübingen, Germany – sequence: 5 givenname: John M. surname: Dean fullname: Dean, John M. organization: Davis Phinney Foundation for Parkinson's, Colorado, Boulder, USA – sequence: 6 givenname: Jochen surname: Klucken fullname: Klucken, Jochen organization: Department of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany – sequence: 7 givenname: Bjoern M. surname: Eskofier fullname: Eskofier, Bjoern M. organization: Digital Sports Group, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany – sequence: 8 givenname: Aristide surname: Merola fullname: Merola, Aristide organization: Department of Neuroscience "Rita Levi Montalcini", Città della salute e della scienza di Torino, Torino, Italy – sequence: 9 givenname: Fay surname: Horak fullname: Horak, Fay organization: Department of Neurology, Oregon Health & Science University, Portland VA Medical System, Portland, Oregon – sequence: 10 givenname: Anthony E. surname: Lang fullname: Lang, Anthony E. organization: Morton and Gloria Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, Toronto, Canada – sequence: 11 givenname: Ralf surname: Reilmann fullname: Reilmann, Ralf organization: George-Huntington-Institute, Muenster, Germany – sequence: 12 givenname: Joe surname: Giuffrida fullname: Giuffrida, Joe organization: Great Lakes NeuroTechnologies, Ohio, Cleveland, USA – sequence: 13 givenname: Alice surname: Nieuwboer fullname: Nieuwboer, Alice organization: Neuromotor Rehabilitation Research Group, Department of Rehabilitation Sciences, KU Leuven, Leuven, Belgium – sequence: 14 givenname: Malcolm surname: Horne fullname: Horne, Malcolm organization: Global Kinetics Corporation & Florey Institute for Neuroscience and Mental Health, University of Melbourne, Victoria, Parkville, Australia – sequence: 15 givenname: Max A. surname: Little fullname: Little, Max A. organization: Department of Mathematics, Aston University, Birmingham, UK – sequence: 16 givenname: Irene surname: Litvan fullname: Litvan, Irene organization: Department of Neurosciences, University of California San Diego, CA, La Jolla, USA – sequence: 17 givenname: Tanya surname: Simuni fullname: Simuni, Tanya organization: Department of Neurology, Feinberg School of Medicine, Northwestern University, Illinois, Chicago, USA – sequence: 18 givenname: E. Ray surname: Dorsey fullname: Dorsey, E. Ray organization: Department of Neurology, University of Rochester Medical Center, New York, Rochester, USA – sequence: 19 givenname: Michelle A. surname: Burack fullname: Burack, Michelle A. organization: Department of Neurology, University of Rochester Medical Center, New York, Rochester, USA – sequence: 20 givenname: Ken surname: Kubota fullname: Kubota, Ken organization: Michael J Fox Foundation for Parkinson's Research, New York, New York City, USA – sequence: 21 givenname: Anita surname: Kamondi fullname: Kamondi, Anita organization: Department of Neurology, National Institute of Clinical Neurosciences, Budapest, Hungary – sequence: 22 givenname: Catarina surname: Godinho fullname: Godinho, Catarina organization: Center of Interdisciplinary Research Egas Moniz (CiiEM), Instituto Superior de Ciências da Saúde Egas Moniz, Monte de Caparica, Portugal – sequence: 23 givenname: Jean-Francois surname: Daneault fullname: Daneault, Jean-Francois organization: Department of Physical Medicine and Rehabilitation, Harvard Medical School, Massachusetts, Boston, USA – sequence: 24 givenname: Georgia surname: Mitsi fullname: Mitsi, Georgia organization: Apptomics LLC, Massachusetts, Wellesley, USA – sequence: 25 givenname: Lothar surname: Krinke fullname: Krinke, Lothar organization: Medtronic Neuromodulation, Minnesota, Minneapolis, USA – sequence: 26 givenname: Jeffery M. surname: Hausdorff fullname: Hausdorff, Jeffery M. organization: Sackler School of Medicine, Tel Aviv University and Center for the Study of Movement, Cognition, and Mobility, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel – sequence: 27 givenname: Bastiaan R. surname: Bloem fullname: Bloem, Bastiaan R. organization: Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Nijmegen, the Netherlands – sequence: 28 givenname: Spyros surname: Papapetropoulos fullname: Papapetropoulos, Spyros organization: Massachusetts General Hospital, Massachusetts, Boston, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27125836$$D View this record in MEDLINE/PubMed |
BookMark | eNqN0btOwzAUBmALgaAFBl4ARWKAJeBLbJ-wICjQInEVRYyWE7tgSO0SN4K-PaEFBiYmH8nfb8nn76JlH7xFaIvgfYIxPRibuE-FyOgS6hDOSAqUy2XUwQA8ZQT4GurG-IIxIZyIVbRGJaEcmOigo6Etn32owtMscT651fWr8zH43ZgYF62O9jDpPeuqsv7JxkR7k4TJJNTTxrups3EDrYx0Fe3m97mOHs7Phr1BennTv-gdX6YuA0xTY_IyL6UgAgiBQgDQnEtmMs1EQamxheR8ZHIoOR2BJhoXWYFLziHnGQNg62hv8e6kDm-NjVM1drG0VaW9DU1UBKjMMQMp_kGJBM4y_EV3_tCX0NS-_chc4QwAs1Ztf6umGFujJrUb63qmfrbYgoMFeHeVnf3eE6y-6lFtPWpej7o6vZ8PbSJdJFyc2o_fRLt9JSSTXD1e9xXc3j0O7vOhOmGfQfGP9Q |
CODEN | MOVDEA |
ContentType | Journal Article |
Copyright | 2016 International Parkinson and Movement Disorder Society 2016 International Parkinson and Movement Disorder Society. |
Copyright_xml | – notice: 2016 International Parkinson and Movement Disorder Society – notice: 2016 International Parkinson and Movement Disorder Society. |
CorporateAuthor | Movement Disorders Society Task Force on Technology |
CorporateAuthor_xml | – name: Movement Disorders Society Task Force on Technology |
DBID | BSCLL CGR CUY CVF ECM EIF NPM 7TK 8FD FR3 K9. NAPCQ P64 RC3 7X8 |
DOI | 10.1002/mds.26642 |
DatabaseName | Istex Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts Technology Research Database Engineering Research Database ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Nursing & Allied Health Premium Genetics Abstracts Technology Research Database ProQuest Health & Medical Complete (Alumni) Engineering Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Nursing & Allied Health Premium Neurosciences Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1531-8257 |
EndPage | 1282 |
ExternalDocumentID | 4172280841 27125836 MDS26642 ark_67375_WNG_8PQWHS9T_B |
Genre | reviewArticle Research Support, U.S. Gov't, Non-P.H.S Review Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIA NIH HHS grantid: R01 AG006457 – fundername: NINDS NIH HHS grantid: P20 NS092529 – fundername: NIA NIH HHS grantid: P50 AG005131 – fundername: CIHR – fundername: NCATS NIH HHS grantid: UL1 TR000460 – fundername: NHLBI NIH HHS grantid: T35 HL007491 – fundername: NIMH NIH HHS grantid: K23 MH092735 – fundername: Parkinson's UK grantid: J-0901 – fundername: NINDS NIH HHS grantid: U54 NS092089 – fundername: NINDS NIH HHS grantid: R01 NS073683 |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 123 1CY 1L6 1OB 1OC 1ZS 31~ 33P 3PY 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5VS 66C 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAWTL AAXRX AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR1 DR2 DRFUL DRMAN DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC FYBCS G-S G.N GNP GODZA H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M6M MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RWD RWI RX1 RYL SAMSI SUPJJ SV3 TEORI TWZ UB1 V2E V9Y W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WRC WUP WVDHM WXI WXSBR XG1 XV2 YCJ ZGI ZZTAW ~IA ~WT AAHQN AAIPD AAMNL AANHP AAYCA ACRPL ACYXJ ADNMO AFWVQ ALVPJ AAMMB AEFGJ AEYWJ AGHNM AGQPQ AGXDD AGYGG AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7TK 8FD FR3 K9. NAPCQ P64 RC3 7X8 |
ID | FETCH-LOGICAL-i4802-dd9c9c76168118b68829573d4a36b22deb755fd98c52f8a1a0b4b0c5589543883 |
IEDL.DBID | DR2 |
ISSN | 0885-3185 |
IngestDate | Fri Jul 11 02:08:08 EDT 2025 Fri Jul 11 02:27:03 EDT 2025 Sun Jul 13 02:48:41 EDT 2025 Mon Jul 21 06:03:53 EDT 2025 Wed Jan 22 16:26:42 EST 2025 Wed Oct 30 09:57:24 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | digital biomarkers Parkinson's disease digital health precision medicine remote monitoring technology wearable technology eHealth |
Language | English |
License | 2016 International Parkinson and Movement Disorder Society. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-i4802-dd9c9c76168118b68829573d4a36b22deb755fd98c52f8a1a0b4b0c5589543883 |
Notes | ark:/67375/WNG-8PQWHS9T-B ArticleID:MDS26642 istex:014A11677B7C736F17A0D30BED2AAE676D8D2F78 The MDS Technology Task Force assembled a group of experts from the device and biopharmaceutical industry, clinical researchers, and engineers. The authors have taken every effort to minimize the influence of their home institutions and industries on the summarized outcome of the deliberations. A.J.E. has received grant support from Great Lakes Neurotechnologies. He serves as chair of the MDS Technology Task Force. P.B. is supported by the Michael J Fox Foundation, the National Institutes of Health, the National Science Foundation, and the Office of Naval Research. F.N. has received an educational grant from Medtronic Inc. W.M. has received grants from the European Union for FAIR‐PARK‐II, Moving beyond and SENSE‐PARK. J.M.D. is supported by the Davis Phinney Foundation to direct their Healthcare Strategy and Technology division. J.K. has received grant support Astrum IT and LicherMT and is chair of the task force “sensor‐based movement analysis” of the German Parkinson Society. B.M.E. has received grant support from Bosch Sensortec and Astrum IT and is co‐chair of the task force “sensor‐based movement analysis” of the German Parkinson Society. F.H. has research grants from Medtronic and has an equity/interest in APDM, a technology company. A.E.L. has served as an advisor for and received honoraria from Medtronic. R.R. is founding director and owner of the George‐Huntington‐Institute, a private research institute and QuantiMedis, a clinical research organization providing Q‐Motor (quantitative motor) services in clinical trials and research. J.G. is a full‐time employee of Great Lakes Neurotechnologies. M.H. has a financial interest in Global Kinetics Corporation, a company that manufactures and supplies the Parkinson's KinetiGraph (PKG), a wearable technology. M.A.L. has nothing to disclose. T.S. has received funding support for educational programming from GE Medical and Medtronic. E.R.D. has filed for a patent related to telemedicine and neurology and has received research funding from Great Lakes Neurotechnologies and Prana Biotechnology. K.K. directs data science and the partnership with Intel on wearable technologies and analytics enacted through the Michael J Fox Foundation for Parkinson's Research full time. G.M. is the founder and chief executive officer of Apptomics LLC. L.K. is a full‐time employee of Medtronic and serves as Board Observer at Functional Neuromodulation, Ltd. J.M.H. submitted a patent application on the use of body‐fixed sensors in Parkinson disease. The intellectual property rights for this patent application are held by the Tel Aviv Sourasky Medical Center. B.R.B. received research support from the Netherlands Organization for Scientific Research, the Michael J Fox Foundation, the Prinses Beatrix Foundation, the Stichting Parkinson Fonds, the National Parkinson Foundation, the Hersenstichting Nederland and the Parkinson Vereniging. S.P. is a full‐time employee of TEVA Pharmaceuticals. He serves as co‐chair of the MDS Technology Task Force. All other authors have no financial disclosure to report related to research covered in this article. Relevant conflicts of interests/financial disclosures ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Feature-3 content type line 23 ObjectType-Review-2 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.26642 |
PMID | 27125836 |
PQID | 1817048803 |
PQPubID | 1016421 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_1827903876 proquest_miscellaneous_1817853406 proquest_journals_1817048803 pubmed_primary_27125836 wiley_primary_10_1002_mds_26642_MDS26642 istex_primary_ark_67375_WNG_8PQWHS9T_B |
PublicationCentury | 2000 |
PublicationDate | September 2016 |
PublicationDateYYYYMMDD | 2016-09-01 |
PublicationDate_xml | – month: 09 year: 2016 text: September 2016 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Hoboken |
PublicationTitle | Movement disorders |
PublicationTitleAlternate | Mov Disord |
PublicationYear | 2016 |
Publisher | Blackwell Publishing Ltd Wiley Subscription Services, Inc |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Wiley Subscription Services, Inc |
References | Del Din S, Godfrey A, Rochester L. Validation of an accelerometer to quantify a comprehensive battery of gait characteristics in healthy older adults and Parkinson's disease: toward clinical and at home use. IEEE J Biomed Health Inform 2015 [Epub ahead of print]. Roy SH, Cole BT, Gilmore LD, et al. High-resolution tracking of motor disorders in Parkinson's disease during unconstrained activity. Mov Disord 2013;28(8):1080-1087. Ellis T, Cavanaugh JT, Earhart GM, Ford MP, Foreman KB, Dibble LE. Which measures of physical function and motor impairment best predict quality of life in Parkinson's disease? Parkinsonism Relat Disord 2011;17(9):693-697. Mariani B, Jimenez MC, Vingerhoets FJ, Aminian K. On-shoe wearable sensors for gait and turning assessment of patients with Parkinson's disease. IEEE Trans Biomed Eng 2013;60(1):155-158. Fereshtehnejad SM, Romenets SR, Anang JB, Latreille V, Gagnon JF, Postuma RB. New clinical subtypes of parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes. JAMA Neurol 2015;72(8):863-873. Berganzo K, Tijero B, Gonzalez-Eizaguirre A, et al. Motor and non-motor symptoms of Parkinson's disease and their impact on quality of life and on different clinical subgroups. Neurologia 2014, pii: S0213-4853(14)00233-3, doi: 10.1016/j.nrl.2014.10.010. Lieber B, Taylor BE, Appelboom G, McKhann G, Connolly ES Jr. Motion sensors to assess and monitor medical and surgical management of Parkinson disease. World Neurosurg 2015;84(2):561-566. Papapetropoulos S, Mitsi G, Espay AJ. Digital health revolution: is it time for affordable remote monitoring for Parkinson's disease? Front Neurol 2015;6:34. Bonato P. Wearable sensors and systems. From enabling technology to clinical applications. IEEE Eng Med Biol Mag 2010;29(3):25-36. Chen BR, Patel S, Buckley T, et al. A web-based system for home monitoring of patients with Parkinson's disease using wearable sensors. IEEE Trans Biomed Eng 2011;58(3):831-836. Arora S, Venkataraman V, Zhan A, et al. Detecting and monitoring the symptoms of Parkinson's disease using smartphones: a pilot study. Parkinsonism Relat Disord 2015;21(6):650-653. Thenganatt MA, Jankovic J. Parkinson disease subtypes. JAMA Neurol 2014;71(4):499-504. Bachlin M, Plotnik M, Roggen D, et al. Wearable assistant for Parkinson's disease patients with the freezing of gait symptom. IEEE Trans Inf Technol Biomed 2010;14(2):436-446. Espay AJ, Giuffrida JP, Chen R, et al. Differential response of speed, amplitude, and rhythm to dopaminergic medications in Parkinson's disease. Mov Disord 2011;26(14):2504-2508. Mendiola MF, Kalnicki M, Lindenauer S. Valuable features in mobile health apps for patients and consumers: content analysis of apps and user ratings. JMIR Mhealth Uhealth 2015;3(2):e40. Consumer Intelligence Series: The Wearable Future. Pricewaterhouse Coopers. http://www.pwc.com/us/en/retail-consumer/publications/assets/pwc-cis-wearable-future.pdf Ozinga SJ, Machado AG, Miller Koop M, Rosenfeldt AB, Alberts JL. Objective assessment of postural stability in Parkinson's disease using mobile technology. Mov Disord 2015;30(9):1214-1221. Fisher JM, Hammerla NY, Rochester L, Andras P, Walker RW. Body-worn sensors in Parkinson's disease: evaluating their acceptability to patients. Telemed J E Health 2016;22:63-69. Horak FB, Mancini M. Objective biomarkers of balance and gait for Parkinson's disease using body-worn sensors. Mov Disord 2013;28(11):1544-1551. Quinn EJ, Blumenfeld Z, Velisar A, et al. Beta oscillations in freely moving Parkinson's subjects are attenuated during deep brain stimulation. Mov Disord 2015;30:1750-1758. Liu G, Ho C, Slappey N, et al. A wearable conductivity sensor for wireless real-time sweat monitoring. Sensors Actuat B Chem 2016;227:35-42. Jankovic J. Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations. Mov Disord 2005;20(suppl 11):S11-S16. Shukla P, Basu I, Tuninetti D. Towards closed-loop deep brain stimulation: decision tree-based essential tremor patient's state classifier and tremor reappearance predictor. Conf Proc IEEE Eng Med Biol Soc 2014;2014:2605-2608. McCall C, McCall WV. Comparison of actigraphy with polysomnography and sleep logs in depressed insomniacs. J Sleep Res 2012;21(1):122-127. Hellman AM, Shah SP, Pawlowski SM, Duda JE, Morley JF. Continuous non-invasive monitoring to detect covert autonomic dysfunction in Parkinson's disease. Parkinsonism Relat Disord 2015;21(7):723-728. Klucken J, Barth J, Kugler P, et al. Unbiased and mobile gait analysis detects motor impairment in Parkinson's disease. PLoS ONE 2013;8(2):e56956. Son D, Lee J, Qiao S, et al. Multifunctional wearable devices for diagnosis and therapy of movement disorders. Nat Nanotechnol 2014;9(5):397-404. Shull PB, Jirattigalachote W, Hunt MA, Cutkosky MR, Delp SL. Quantified self and human movement: a review on the clinical impact of wearable sensing and feedback for gait analysis and intervention. Gait Posture 2014;40(1):11-19. Maetzler W, Domingos J, Srulijes K, Ferreira JJ, Bloem BR. Quantitative wearable sensors for objective assessment of Parkinson's disease. Mov Disord 2013;28(12):1628-1637. Rahimi F, Bee C, Duval C, et al. Using ecological whole body kinematics to evaluate effects of medication adjustment in Parkinson disease. J Parkinsons Dis 2014;4(4):617-627. Weiss A, Herman T, Giladi N, Hausdorff JM. Objective assessment of fall risk in Parkinson's disease using a body-fixed sensor worn for 3 days. PLoS ONE 2014;9(5):e96675. Das S, Trutoiu L, Murai A, et al. Quantitative measurement of motor symptoms in Parkinson's disease: a study with full-body motion capture data. Conf Proc IEEE Eng Med Biol Soc 2011;2011:6789-6792. Mazilu S, Calatroni A, Gazit E, Mirelman A, Hausdorff JM, Troster G. Prediction of freezing of gait in parkinson's from physiological wearables: an exploratory study. IEEE J Biomed Health Inform 2015;19(6):1843-1854. Ferreira JJ, Godinho C, Santos AT, et al. Quantitative home-based assessment of Parkinson's symptoms: the SENSE-PARK feasibility and usability study. BMC Neurol 2015;15:89. Moore ST, Yungher DA, Morris TR, et al. Autonomous identification of freezing of gait in Parkinson's disease from lower-body segmental accelerometry. J Neuroeng Rehabil 2013;10:19. Guo Y, Graber A, McBurney RN, Balasubramanian R. Sample size and statistical power considerations in high-dimensionality data settings: a comparative study of classification algorithms. BMC Bioinformatics 2010;11:447. Zheng YL, Ding XR, Poon CC, et al. Unobtrusive sensing and wearable devices for health informatics. IEEE Trans Biomed Eng 2014;61(5):1538-1554. Mera TO, Burack MA, Giuffrida JP. Quantitative assessment of levodopa-induced dyskinesia using automated motion sensing technology. Conf Proc IEEE Eng Med Biol Soc 2012;2012:154-157. Patel S, Lorincz K, Hughes R, et al. Monitoring motor fluctuations in patients with Parkinson's disease using wearable sensors. IEEE Trans Inf Technol Biomed 2009;13(6):864-873. Maetzler W, Liepelt I, Berg D. Progression of Parkinson's disease in the clinical phase: potential markers. Lancet Neurol 2009;8(12):1158-1171. Horak F, King L, Mancini M. Role of body-worn movement monitor technology for balance and gait rehabilitation. Phys Ther 2015;95(3):461-470. Nieuwboer A, De Weerdt W, Dom R, Lesaffre E. A frequency and correlation analysis of motor deficits in Parkinson patients. Disabil Rehabil 1998;20(4):142-150. Cavanaugh JT, Ellis TD, Earhart GM, Ford MP, Foreman KB, Dibble LE. Capturing ambulatory activity decline in Parkinson's disease. J Neurol Phys Ther 2012;36(2):51-57. Stamford JA, Schmidt PN, Friedl KE. What engineering technology could do for quality of life in Parkinson's disease: a review of current needs and opportunities. IEEE J Biomed Health Inform 2015;19(6):1862-1872. Rampp A, Barth J, Schulein S, Gassmann KG, Klucken J, Eskofier BM. Inertial sensor-based stride parameter calculation from gait sequences in geriatric patients. IEEE Trans Biomed Eng 2015;62(4):1089-1097. Goetz CG, Stebbins GT, Wolff D, et al. Testing objective measures of motor impairment in early Parkinson's disease: feasibility study of an at-home testing device. Mov Disord 2009;24(4):551-556. Cazalé A, Sant W, Ginot F, et al. Physiological stress monitoring using sodium ion potentiometric microsensors for sweat analysis. Sensors Actuat B Chem 2016;225:1-9. Pasluosta CF, Gassner H, Winkler J, Klucken J, Eskofier BM. An emerging era in the management of parkinson's disease: wearable technologies and the internet of things. IEEE J Biomed Health Inform 2015;19(6):1873-1881. Basu I, Graupe D, Tuninetti D, et al. Pathological tremor prediction using surface electromyogram and acceleration: potential use in "ON-OFF" demand driven deep brain stimulator design. J Neural Eng 2013;10(3):036019. Brun L, Lefaucheur R, Fetter D, et al. Non-motor fluctuations in Parkinson's disease: prevalence, characteristics and management in a large cohort of parkinsonian outpatients. Clin Neurol Neurosurg 2014;127:93-96. Valappil RA, Black JE, Broderick MJ, et al. Exploring the electrocardiogram as a potential tool to screen for premotor Parkinson's disease. Mov Disord 2010;25(14):2296-2303. Bayestehtashk A, Asgari M, Shafran I, McNames J. Fully automated assessment of the severity of Parkinson's disease from speech. Comput Speech Lang 2015;29(1):172-185. Hubble RP, Naughton GA, Silburn PA, Cole MH. Wearable sensor use for assessing standing balance and walking stability in people with Parkinson's disease: a systematic review. PLoS ONE 2015;10(4):e0123705. Wang H, Jafari R, Zhou G, et al. Guest Editorial: Special Issue on Internet of Things for Smart and Connected Health. IEEE IoT J 2015;2(1):1-4. Solla P, Cadeddu C, Cannas A, et al. Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype. J Neural Transm 2015:1-6. Hung SW, Adeli GM, Arenovich T, Fox SH, Lang AE. Patien 2015; 2 2010; 11 2015; 15 2009; 24 2015; 6 2012; 2012 2015; 19 2013; 28 2010; 14 2015; 3 2015; 95 2015; 72 2015; 30 2015; 10 2016; 222 2005; 20 2016; 227 2014; 2014 2016; 225 2011; 58 2012; 36 2011; 17 2010; 81 2014; 40 2013; 8 2014; 61 1998; 20 2011; 2011 2014; 127 2009; 13 2014; 4 2010; 25 2015; 29 2013; 10 2010; 29 2015; 84 2015; 62 2015; 21 2013; 60 2009; 8 2015 2011; 26 2014 2014; 9 2014; 71 2012; 21 2016; 22 |
References_xml | – reference: Ferreira JJ, Godinho C, Santos AT, et al. Quantitative home-based assessment of Parkinson's symptoms: the SENSE-PARK feasibility and usability study. BMC Neurol 2015;15:89. – reference: Horak F, King L, Mancini M. Role of body-worn movement monitor technology for balance and gait rehabilitation. Phys Ther 2015;95(3):461-470. – reference: Ozinga SJ, Machado AG, Miller Koop M, Rosenfeldt AB, Alberts JL. Objective assessment of postural stability in Parkinson's disease using mobile technology. Mov Disord 2015;30(9):1214-1221. – reference: Pasluosta CF, Gassner H, Winkler J, Klucken J, Eskofier BM. An emerging era in the management of parkinson's disease: wearable technologies and the internet of things. IEEE J Biomed Health Inform 2015;19(6):1873-1881. – reference: Weiss A, Herman T, Giladi N, Hausdorff JM. Objective assessment of fall risk in Parkinson's disease using a body-fixed sensor worn for 3 days. PLoS ONE 2014;9(5):e96675. – reference: Zheng YL, Ding XR, Poon CC, et al. Unobtrusive sensing and wearable devices for health informatics. IEEE Trans Biomed Eng 2014;61(5):1538-1554. – reference: Wang H, Jafari R, Zhou G, et al. Guest Editorial: Special Issue on Internet of Things for Smart and Connected Health. IEEE IoT J 2015;2(1):1-4. – reference: Ledger D, McCaffrey D. Inside wearables: how the science of human behavior change offers the secret to long-term engagement. In: LLC EP, Dan Ledger and Daniel McCarey, eds. Endeavour Partners LLC; Cambridge, MA, 2014;1-17. – reference: Maetzler W, Domingos J, Srulijes K, Ferreira JJ, Bloem BR. Quantitative wearable sensors for objective assessment of Parkinson's disease. Mov Disord 2013;28(12):1628-1637. – reference: Horak FB, Mancini M. Objective biomarkers of balance and gait for Parkinson's disease using body-worn sensors. Mov Disord 2013;28(11):1544-1551. – reference: Maetzler W, Liepelt I, Berg D. Progression of Parkinson's disease in the clinical phase: potential markers. Lancet Neurol 2009;8(12):1158-1171. – reference: Hubble RP, Naughton GA, Silburn PA, Cole MH. Wearable sensor use for assessing standing balance and walking stability in people with Parkinson's disease: a systematic review. PLoS ONE 2015;10(4):e0123705. – reference: Moore ST, Yungher DA, Morris TR, et al. Autonomous identification of freezing of gait in Parkinson's disease from lower-body segmental accelerometry. J Neuroeng Rehabil 2013;10:19. – reference: Mazilu S, Calatroni A, Gazit E, Mirelman A, Hausdorff JM, Troster G. Prediction of freezing of gait in parkinson's from physiological wearables: an exploratory study. IEEE J Biomed Health Inform 2015;19(6):1843-1854. – reference: Rampp A, Barth J, Schulein S, Gassmann KG, Klucken J, Eskofier BM. Inertial sensor-based stride parameter calculation from gait sequences in geriatric patients. IEEE Trans Biomed Eng 2015;62(4):1089-1097. – reference: Shull PB, Jirattigalachote W, Hunt MA, Cutkosky MR, Delp SL. Quantified self and human movement: a review on the clinical impact of wearable sensing and feedback for gait analysis and intervention. Gait Posture 2014;40(1):11-19. – reference: Hellman AM, Shah SP, Pawlowski SM, Duda JE, Morley JF. Continuous non-invasive monitoring to detect covert autonomic dysfunction in Parkinson's disease. Parkinsonism Relat Disord 2015;21(7):723-728. – reference: Valappil RA, Black JE, Broderick MJ, et al. Exploring the electrocardiogram as a potential tool to screen for premotor Parkinson's disease. Mov Disord 2010;25(14):2296-2303. – reference: Patel S, Lorincz K, Hughes R, et al. Monitoring motor fluctuations in patients with Parkinson's disease using wearable sensors. IEEE Trans Inf Technol Biomed 2009;13(6):864-873. – reference: Lieber B, Taylor BE, Appelboom G, McKhann G, Connolly ES Jr. Motion sensors to assess and monitor medical and surgical management of Parkinson disease. World Neurosurg 2015;84(2):561-566. – reference: Liu G, Ho C, Slappey N, et al. A wearable conductivity sensor for wireless real-time sweat monitoring. Sensors Actuat B Chem 2016;227:35-42. – reference: Solla P, Cadeddu C, Cannas A, et al. Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype. J Neural Transm 2015:1-6. – reference: Klucken J, Barth J, Kugler P, et al. Unbiased and mobile gait analysis detects motor impairment in Parkinson's disease. PLoS ONE 2013;8(2):e56956. – reference: Sommerauer M, Imbach LL, Jarallah M, Baumann CR, Valko PO. Diminished event-related cortical arousals and altered heart rate response in Parkinson's disease. Mov Disord 2015;30(6):866-870. – reference: Stamford JA, Schmidt PN, Friedl KE. What engineering technology could do for quality of life in Parkinson's disease: a review of current needs and opportunities. IEEE J Biomed Health Inform 2015;19(6):1862-1872. – reference: Roy SH, Cole BT, Gilmore LD, et al. High-resolution tracking of motor disorders in Parkinson's disease during unconstrained activity. Mov Disord 2013;28(8):1080-1087. – reference: Rahimi F, Bee C, Duval C, et al. Using ecological whole body kinematics to evaluate effects of medication adjustment in Parkinson disease. J Parkinsons Dis 2014;4(4):617-627. – reference: Shen X, Mak MK. Technology-assisted balance and gait training reduces falls in patients with Parkinson's disease: a randomized controlled trial with 12-month follow-up. Neurorehabil Neural Repair 2015;29(2):103-111. – reference: Son D, Lee J, Qiao S, et al. Multifunctional wearable devices for diagnosis and therapy of movement disorders. Nat Nanotechnol 2014;9(5):397-404. – reference: Berganzo K, Tijero B, Gonzalez-Eizaguirre A, et al. Motor and non-motor symptoms of Parkinson's disease and their impact on quality of life and on different clinical subgroups. Neurologia 2014, pii: S0213-4853(14)00233-3, doi: 10.1016/j.nrl.2014.10.010. – reference: Espay AJ, Giuffrida JP, Chen R, et al. Differential response of speed, amplitude, and rhythm to dopaminergic medications in Parkinson's disease. Mov Disord 2011;26(14):2504-2508. – reference: Nieuwboer A, De Weerdt W, Dom R, Lesaffre E. A frequency and correlation analysis of motor deficits in Parkinson patients. Disabil Rehabil 1998;20(4):142-150. – reference: Hung SW, Adeli GM, Arenovich T, Fox SH, Lang AE. Patient perception of dyskinesia in Parkinson's disease. J Neurol Neurosurg Psychiatry 2010;81(10):1112-1115. – reference: Ellis T, Cavanaugh JT, Earhart GM, Ford MP, Foreman KB, Dibble LE. Which measures of physical function and motor impairment best predict quality of life in Parkinson's disease? Parkinsonism Relat Disord 2011;17(9):693-697. – reference: Quinn EJ, Blumenfeld Z, Velisar A, et al. Beta oscillations in freely moving Parkinson's subjects are attenuated during deep brain stimulation. Mov Disord 2015;30:1750-1758. – reference: Fisher JM, Hammerla NY, Rochester L, Andras P, Walker RW. Body-worn sensors in Parkinson's disease: evaluating their acceptability to patients. Telemed J E Health 2016;22:63-69. – reference: Fereshtehnejad SM, Romenets SR, Anang JB, Latreille V, Gagnon JF, Postuma RB. New clinical subtypes of parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes. JAMA Neurol 2015;72(8):863-873. – reference: Del Din S, Godfrey A, Rochester L. Validation of an accelerometer to quantify a comprehensive battery of gait characteristics in healthy older adults and Parkinson's disease: toward clinical and at home use. IEEE J Biomed Health Inform 2015 [Epub ahead of print]. – reference: Brun L, Lefaucheur R, Fetter D, et al. Non-motor fluctuations in Parkinson's disease: prevalence, characteristics and management in a large cohort of parkinsonian outpatients. Clin Neurol Neurosurg 2014;127:93-96. – reference: Mera TO, Burack MA, Giuffrida JP. Quantitative assessment of levodopa-induced dyskinesia using automated motion sensing technology. Conf Proc IEEE Eng Med Biol Soc 2012;2012:154-157. – reference: McCall C, McCall WV. Comparison of actigraphy with polysomnography and sleep logs in depressed insomniacs. J Sleep Res 2012;21(1):122-127. – reference: Papapetropoulos S, Mitsi G, Espay AJ. Digital health revolution: is it time for affordable remote monitoring for Parkinson's disease? Front Neurol 2015;6:34. – reference: Cazalé A, Sant W, Ginot F, et al. Physiological stress monitoring using sodium ion potentiometric microsensors for sweat analysis. Sensors Actuat B Chem 2016;225:1-9. – reference: Cavanaugh JT, Ellis TD, Earhart GM, Ford MP, Foreman KB, Dibble LE. Capturing ambulatory activity decline in Parkinson's disease. J Neurol Phys Ther 2012;36(2):51-57. – reference: Mendiola MF, Kalnicki M, Lindenauer S. Valuable features in mobile health apps for patients and consumers: content analysis of apps and user ratings. JMIR Mhealth Uhealth 2015;3(2):e40. – reference: Shukla P, Basu I, Tuninetti D. Towards closed-loop deep brain stimulation: decision tree-based essential tremor patient's state classifier and tremor reappearance predictor. Conf Proc IEEE Eng Med Biol Soc 2014;2014:2605-2608. – reference: Goetz CG, Stebbins GT, Wolff D, et al. Testing objective measures of motor impairment in early Parkinson's disease: feasibility study of an at-home testing device. Mov Disord 2009;24(4):551-556. – reference: Bonato P. Wearable sensors and systems. From enabling technology to clinical applications. IEEE Eng Med Biol Mag 2010;29(3):25-36. – reference: Jankovic J. Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations. Mov Disord 2005;20(suppl 11):S11-S16. – reference: Caldara M, Colleoni C, Guido E, Re V, Rosace G. Optical monitoring of sweat pH by a textile fabric wearable sensor based on covalently bonded litmus-3-glycidoxypropyltrimethoxysilane coating. Sensors Actuat B Chem 2016;222:213-220. – reference: Mariani B, Jimenez MC, Vingerhoets FJ, Aminian K. On-shoe wearable sensors for gait and turning assessment of patients with Parkinson's disease. IEEE Trans Biomed Eng 2013;60(1):155-158. – reference: Arora S, Venkataraman V, Zhan A, et al. Detecting and monitoring the symptoms of Parkinson's disease using smartphones: a pilot study. Parkinsonism Relat Disord 2015;21(6):650-653. – reference: Bayestehtashk A, Asgari M, Shafran I, McNames J. Fully automated assessment of the severity of Parkinson's disease from speech. Comput Speech Lang 2015;29(1):172-185. – reference: Thenganatt MA, Jankovic J. Parkinson disease subtypes. JAMA Neurol 2014;71(4):499-504. – reference: Bachlin M, Plotnik M, Roggen D, et al. Wearable assistant for Parkinson's disease patients with the freezing of gait symptom. IEEE Trans Inf Technol Biomed 2010;14(2):436-446. – reference: Basu I, Graupe D, Tuninetti D, et al. Pathological tremor prediction using surface electromyogram and acceleration: potential use in "ON-OFF" demand driven deep brain stimulator design. J Neural Eng 2013;10(3):036019. – reference: Guo Y, Graber A, McBurney RN, Balasubramanian R. Sample size and statistical power considerations in high-dimensionality data settings: a comparative study of classification algorithms. BMC Bioinformatics 2010;11:447. – reference: Chen BR, Patel S, Buckley T, et al. A web-based system for home monitoring of patients with Parkinson's disease using wearable sensors. IEEE Trans Biomed Eng 2011;58(3):831-836. – reference: Consumer Intelligence Series: The Wearable Future. Pricewaterhouse Coopers. http://www.pwc.com/us/en/retail-consumer/publications/assets/pwc-cis-wearable-future.pdf – reference: Das S, Trutoiu L, Murai A, et al. Quantitative measurement of motor symptoms in Parkinson's disease: a study with full-body motion capture data. Conf Proc IEEE Eng Med Biol Soc 2011;2011:6789-6792. – volume: 8 start-page: e56956 issue: 2 year: 2013 article-title: Unbiased and mobile gait analysis detects motor impairment in Parkinson's disease publication-title: PLoS ONE – volume: 72 start-page: 863 issue: 8 year: 2015 end-page: 873 article-title: New clinical subtypes of parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes publication-title: JAMA Neurol – volume: 6 start-page: 34 year: 2015 article-title: Digital health revolution: is it time for affordable remote monitoring for Parkinson's disease? publication-title: Front Neurol – volume: 26 start-page: 2504 issue: 14 year: 2011 end-page: 2508 article-title: Differential response of speed, amplitude, and rhythm to dopaminergic medications in Parkinson's disease publication-title: Mov Disord – volume: 36 start-page: 51 issue: 2 year: 2012 end-page: 57 article-title: Capturing ambulatory activity decline in Parkinson's disease publication-title: J Neurol Phys Ther – volume: 60 start-page: 155 issue: 1 year: 2013 end-page: 158 article-title: On‐shoe wearable sensors for gait and turning assessment of patients with Parkinson's disease publication-title: IEEE Trans Biomed Eng – volume: 227 start-page: 35 year: 2016 end-page: 42 article-title: A wearable conductivity sensor for wireless real‐time sweat monitoring publication-title: Sensors Actuat B Chem – volume: 22 start-page: 63 year: 2016 end-page: 69 article-title: Body‐worn sensors in Parkinson's disease: evaluating their acceptability to patients publication-title: Telemed J E Health – volume: 30 start-page: 866 issue: 6 year: 2015 end-page: 870 article-title: Diminished event‐related cortical arousals and altered heart rate response in Parkinson's disease publication-title: Mov Disord – volume: 127 start-page: 93 year: 2014 end-page: 96 article-title: Non‐motor fluctuations in Parkinson's disease: prevalence, characteristics and management in a large cohort of parkinsonian outpatients publication-title: Clin Neurol Neurosurg – volume: 21 start-page: 122 issue: 1 year: 2012 end-page: 127 article-title: Comparison of actigraphy with polysomnography and sleep logs in depressed insomniacs publication-title: J Sleep Res – volume: 13 start-page: 864 issue: 6 year: 2009 end-page: 873 article-title: Monitoring motor fluctuations in patients with Parkinson's disease using wearable sensors publication-title: IEEE Trans Inf Technol Biomed – volume: 14 start-page: 436 issue: 2 year: 2010 end-page: 446 article-title: Wearable assistant for Parkinson's disease patients with the freezing of gait symptom publication-title: IEEE Trans Inf Technol Biomed – volume: 17 start-page: 693 issue: 9 year: 2011 end-page: 697 article-title: Which measures of physical function and motor impairment best predict quality of life in Parkinson's disease? publication-title: Parkinsonism Relat Disord – volume: 29 start-page: 172 issue: 1 year: 2015 end-page: 185 article-title: Fully automated assessment of the severity of Parkinson's disease from speech publication-title: Comput Speech Lang – volume: 225 start-page: 1 year: 2016 end-page: 9 article-title: Physiological stress monitoring using sodium ion potentiometric microsensors for sweat analysis publication-title: Sensors Actuat B Chem – volume: 9 start-page: 397 issue: 5 year: 2014 end-page: 404 article-title: Multifunctional wearable devices for diagnosis and therapy of movement disorders publication-title: Nat Nanotechnol – volume: 19 start-page: 1862 issue: 6 year: 2015 end-page: 1872 article-title: What engineering technology could do for quality of life in Parkinson's disease: a review of current needs and opportunities publication-title: IEEE J Biomed Health Inform – volume: 28 start-page: 1628 issue: 12 year: 2013 end-page: 1637 article-title: Quantitative wearable sensors for objective assessment of Parkinson's disease publication-title: Mov Disord – volume: 19 start-page: 1843 issue: 6 year: 2015 end-page: 1854 article-title: Prediction of freezing of gait in parkinson's from physiological wearables: an exploratory study publication-title: IEEE J Biomed Health Inform – volume: 30 start-page: 1214 issue: 9 year: 2015 end-page: 1221 article-title: Objective assessment of postural stability in Parkinson's disease using mobile technology publication-title: Mov Disord – volume: 61 start-page: 1538 issue: 5 year: 2014 end-page: 1554 article-title: Unobtrusive sensing and wearable devices for health informatics publication-title: IEEE Trans Biomed Eng – start-page: 1 year: 2015 end-page: 6 article-title: Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype publication-title: J Neural Transm – year: 2015 – volume: 10 start-page: e0123705 issue: 4 year: 2015 article-title: Wearable sensor use for assessing standing balance and walking stability in people with Parkinson's disease: a systematic review publication-title: PLoS ONE – volume: 21 start-page: 650 issue: 6 year: 2015 end-page: 653 article-title: Detecting and monitoring the symptoms of Parkinson's disease using smartphones: a pilot study publication-title: Parkinsonism Relat Disord – year: 2015 article-title: Validation of an accelerometer to quantify a comprehensive battery of gait characteristics in healthy older adults and Parkinson's disease: toward clinical and at home use publication-title: IEEE J Biomed Health Inform – volume: 10 start-page: 036019 issue: 3 year: 2013 article-title: Pathological tremor prediction using surface electromyogram and acceleration: potential use in “ON‐OFF” demand driven deep brain stimulator design publication-title: J Neural Eng – volume: 15 start-page: 89 year: 2015 article-title: Quantitative home‐based assessment of Parkinson's symptoms: the SENSE‐PARK feasibility and usability study publication-title: BMC Neurol – volume: 81 start-page: 1112 issue: 10 year: 2010 end-page: 1115 article-title: Patient perception of dyskinesia in Parkinson's disease publication-title: J Neurol Neurosurg Psychiatry – volume: 9 start-page: e96675 issue: 5 year: 2014 article-title: Objective assessment of fall risk in Parkinson's disease using a body‐fixed sensor worn for 3 days publication-title: PLoS ONE – volume: 30 start-page: 1750 year: 2015 end-page: 1758 article-title: Beta oscillations in freely moving Parkinson's subjects are attenuated during deep brain stimulation publication-title: Mov Disord – volume: 2 start-page: 1 issue: 1 year: 2015 end-page: 4 article-title: Guest Editorial: Special Issue on Internet of Things for Smart and Connected Health publication-title: IEEE IoT J – volume: 29 start-page: 103 issue: 2 year: 2015 end-page: 111 article-title: Technology‐assisted balance and gait training reduces falls in patients with Parkinson's disease: a randomized controlled trial with 12‐month follow‐up publication-title: Neurorehabil Neural Repair – volume: 8 start-page: 1158 issue: 12 year: 2009 end-page: 1171 article-title: Progression of Parkinson's disease in the clinical phase: potential markers publication-title: Lancet Neurol – start-page: 8087 year: 2015 end-page: 8090 – volume: 19 start-page: 1873 issue: 6 year: 2015 end-page: 1881 article-title: An emerging era in the management of parkinson's disease: wearable technologies and the internet of things publication-title: IEEE J Biomed Health Inform – volume: 29 start-page: 25 issue: 3 year: 2010 end-page: 36 article-title: Wearable sensors and systems. From enabling technology to clinical applications publication-title: IEEE Eng Med Biol Mag – start-page: 1 year: 2014 end-page: 17 – volume: 28 start-page: 1544 issue: 11 year: 2013 end-page: 1551 article-title: Objective biomarkers of balance and gait for Parkinson's disease using body‐worn sensors publication-title: Mov Disord – volume: 2011 start-page: 6789 year: 2011 end-page: 6792 article-title: Quantitative measurement of motor symptoms in Parkinson's disease: a study with full‐body motion capture data publication-title: Conf Proc IEEE Eng Med Biol Soc – volume: 11 start-page: 447 year: 2010 article-title: Sample size and statistical power considerations in high‐dimensionality data settings: a comparative study of classification algorithms publication-title: BMC Bioinformatics – volume: 28 start-page: 1080 issue: 8 year: 2013 end-page: 1087 article-title: High‐resolution tracking of motor disorders in Parkinson's disease during unconstrained activity publication-title: Mov Disord – volume: 25 start-page: 2296 issue: 14 year: 2010 end-page: 2303 article-title: Exploring the electrocardiogram as a potential tool to screen for premotor Parkinson's disease publication-title: Mov Disord – year: 2014 article-title: Motor and non‐motor symptoms of Parkinson's disease and their impact on quality of life and on different clinical subgroups publication-title: Neurologia – volume: 21 start-page: 723 issue: 7 year: 2015 end-page: 728 article-title: Continuous non‐invasive monitoring to detect covert autonomic dysfunction in Parkinson's disease publication-title: Parkinsonism Relat Disord – volume: 95 start-page: 461 issue: 3 year: 2015 end-page: 470 article-title: Role of body‐worn movement monitor technology for balance and gait rehabilitation publication-title: Phys Ther – volume: 84 start-page: 561 issue: 2 year: 2015 end-page: 566 article-title: Motion sensors to assess and monitor medical and surgical management of Parkinson disease publication-title: World Neurosurg – volume: 2014 start-page: 2605 year: 2014 end-page: 2608 article-title: Towards closed‐loop deep brain stimulation: decision tree‐based essential tremor patient's state classifier and tremor reappearance predictor publication-title: Conf Proc IEEE Eng Med Biol Soc – volume: 4 start-page: 617 issue: 4 year: 2014 end-page: 627 article-title: Using ecological whole body kinematics to evaluate effects of medication adjustment in Parkinson disease publication-title: J Parkinsons Dis – volume: 20 start-page: 142 issue: 4 year: 1998 end-page: 150 article-title: A frequency and correlation analysis of motor deficits in Parkinson patients publication-title: Disabil Rehabil – volume: 71 start-page: 499 issue: 4 year: 2014 end-page: 504 article-title: Parkinson disease subtypes publication-title: JAMA Neurol – volume: 3 start-page: e40 issue: 2 year: 2015 article-title: Valuable features in mobile health apps for patients and consumers: content analysis of apps and user ratings publication-title: JMIR Mhealth Uhealth – volume: 24 start-page: 551 issue: 4 year: 2009 end-page: 556 article-title: Testing objective measures of motor impairment in early Parkinson's disease: feasibility study of an at‐home testing device publication-title: Mov Disord – volume: 58 start-page: 831 issue: 3 year: 2011 end-page: 836 article-title: A web‐based system for home monitoring of patients with Parkinson's disease using wearable sensors publication-title: IEEE Trans Biomed Eng – volume: 10 start-page: 19 year: 2013 article-title: Autonomous identification of freezing of gait in Parkinson's disease from lower‐body segmental accelerometry publication-title: J Neuroeng Rehabil – volume: 222 start-page: 213 year: 2016 end-page: 220 article-title: Optical monitoring of sweat pH by a textile fabric wearable sensor based on covalently bonded litmus‐3‐glycidoxypropyltrimethoxysilane coating publication-title: Sensors Actuat B Chem – volume: 2012 start-page: 154 year: 2012 end-page: 157 article-title: Quantitative assessment of levodopa‐induced dyskinesia using automated motion sensing technology publication-title: Conf Proc IEEE Eng Med Biol Soc – volume: 40 start-page: 11 issue: 1 year: 2014 end-page: 19 article-title: Quantified self and human movement: a review on the clinical impact of wearable sensing and feedback for gait analysis and intervention publication-title: Gait Posture – volume: 20 start-page: S11 issue: suppl 11 year: 2005 end-page: S16 article-title: Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations publication-title: Mov Disord – volume: 62 start-page: 1089 issue: 4 year: 2015 end-page: 1097 article-title: Inertial sensor‐based stride parameter calculation from gait sequences in geriatric patients publication-title: IEEE Trans Biomed Eng |
SSID | ssj0011516 |
Score | 2.6468682 |
SecondaryResourceType | review_article |
Snippet | ABSTRACT
The miniaturization, sophistication, proliferation, and accessibility of technologies are enabling the capture of more and previously inaccessible... The miniaturization, sophistication, proliferation, and accessibility of technologies are enabling the capture of more and previously inaccessible phenomena in... |
SourceID | proquest pubmed wiley istex |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1272 |
SubjectTerms | Biomedical Technology - standards digital biomarkers digital health eHealth Humans Movement disorders Parkinson Disease - diagnosis Parkinson Disease - therapy Parkinson's disease precision medicine remote monitoring technology wearable technology |
Title | Technology in Parkinson's disease: Challenges and opportunities |
URI | https://api.istex.fr/ark:/67375/WNG-8PQWHS9T-B/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fmds.26642 https://www.ncbi.nlm.nih.gov/pubmed/27125836 https://www.proquest.com/docview/1817048803 https://www.proquest.com/docview/1817853406 https://www.proquest.com/docview/1827903876 |
Volume | 31 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3daxQxEA-lD-KLVq31apUVSuvLXnfzHX2QttoehStqW9qHQsjXwiHuFfcOxL--k-xHsYiIbwuZhSSTmfySmfkFoW0lmSGCwDFV0SKn3hW5LR3LlQi4EtaUjsRC4ekpn1zQkyt2tYLe97UwLT_EcOEWLSP562jgxjZ7d6Sh330zht2FRv8bc7UiIPo6UEcB0EnPnoIRsVQh3LMKFXhv-BMAaZzLn39Cl7-D1bTbHD1G130_2ySTb-Plwo7dr3sUjv85kDX0qEOh2X67bJ6glVA_RQ-mXZz9Gfpwd-OezeoslkanKrHdJusiOu-yw_4ZliYztc_mNxHJL-vE0LqOLo4-nR9O8u6phXxGJfhE75VTTvCSSzhxWA64WzFBPDWEW4x9sIKxyivpGK6kKU1hqS0cY1IxSqQkz9FqPa_DC5QZ4alUFcGBYWph-3NSBF7xSgYOWCyM0E6adH3T0mloGELMLhNMX54ea_n5y-XkTJ3rgxHa6rWiO8NqdBkJBaPTISP0ZmgGk4hxDlOH-bKVARQCUOVvMlioGLoHmY1W40OHsADUJwm0vE16GxpaimesQWM6aUxPP56lj81_F32JHgLo4m2e2hZaXfxYhlcAbBb2dVrBt6ky8RA |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VIgEXyquwUMBIPHrJNutHbCMhBF3KlnZXQLdqbyZOHKlCZCuyqwK_ib_Cf2LsPCoQQlx64BbJI8uxZ-xv7JlvAB5qJVImGbqpmscRz7M4soNMRFo6WkibDjLmE4XHk2S0z98cisMl-N7mwtT8EN2Fm7eMsF97A_cX0hunrKGf8qqPxwunTUjljvt6gg5b9Wx7iKv7iNKtV9PNUdTUFIiOuELjz3Od6Qx990QhtLYJAkwtJMt5yhJLae6sFKLItcoELVQ6SGPLbZwJobTgTCmG_Z6D876CuGfqH77vyKoQWoVCq2i2IuQktzxGMd3ohooQ2K_elz_h2V_hcTjftlbgRzszdVjLx_5ibvvZt99II_-XqbsClxugTV7UlnEVllx5DS6Mm1CC6_D89FGBHJXEZ3-HRLgnFWkerZ6SzbbSTEXSMiezY--sLMpAQnsD9s9k-KuwXM5KdwtIKnOudMGoE5RbPOEzJV1SJIVyCcJN14PHYZXNcc0YYvAXfACdFOZg8tqot-8ORnt6al72YK1VA9PsHZUZeM5Ev6-yHjzomtHq_VNOWrrZopZBoIVo7G8yVGofnYAyN2sV6wZEJQJbxbBlPShK11CzWFODGmKChpjxcC983P530ftwcTQd75rd7cnOHbiEGDOpw_LWYHn-eeHuIo6b23vBfAh8OGul-wlKKUyF |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VIlVcyhsWCgSJ1yXbrB-xjYQQdFm2lF0V2qq9mTh2pKoiuyK74vGX-Cv8KMbOowIhxKUHbpE8ihzPjP1NPPMNwAMleUYFxTBVsSRmNk9iM8h5rIQjhTDZIKe-UHgyTccH7M0RP1qB720tTM0P0f1w854R9mvv4HNbbJ6Shn60VR9PF0aajMod9_UzxmvVs-0hKvchIaNX-1vjuGkpEB8zib5vrcpVjqF7KhFZmxTxpeKCWpbR1BBinRGcF1bJnJNCZoMsMcwkOedScUalpPjec3CepYnyfSKG7zuuKkRWoc8qei0PJcktjVFCNrupIgL2yvvyJzj7KzoOx9voIvxoF6bOajnpLxemn3_7jTPyP1m5S7DewOzoRe0Xl2HFlVdgbdIkElyF56dXCtFxGfna71AG97iKmiurp9FW22emirLSRrO5D1WWZaCgvQYHZzL967Bazkp3E6JMWCZVQYnjhBk833MpXFqkhXQpgk3Xg0dByXpe84Vo_ASfPie4Ppy-1nL33eF4T-3rlz3YaK1ANztHpQeeMdHvqrQH97th9Hl_kZOVbrasZRBmIRb7mwwRyucmoMyN2sK6CRGBsFZSHHkS7KQbqDmsiUYL0cFC9GS4Fx5u_bvoPVjbHY702-3pzm24gAAzrXPyNmB18Wnp7iCIW5i7wXki-HDWNvcT8LJLNA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Technology+in+Parkinson%27s+disease%3A+Challenges+and+opportunities&rft.jtitle=Movement+disorders&rft.au=Espay%2C+Alberto+J.&rft.au=Bonato%2C+Paolo&rft.au=Nahab%2C+Fatta+B.&rft.au=Maetzler%2C+Walter&rft.date=2016-09-01&rft.issn=0885-3185&rft.eissn=1531-8257&rft.volume=31&rft.issue=9&rft.spage=1272&rft.epage=1282&rft_id=info:doi/10.1002%2Fmds.26642&rft.externalDBID=10.1002%252Fmds.26642&rft.externalDocID=MDS26642 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0885-3185&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0885-3185&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0885-3185&client=summon |